NCT06089525

Brief Summary

This project intends to compare patient outcomes between patients undergoing ORIF compared to PA, or ankle fusion, following an acute pilon fracture. Limited literature comparing ORIF and ankle fusion as a primary procedure exists. Particularly, no present literature exists examining the novel arthrodesis surgical technique utilized in this study in conjunction with Opal sensor gait analysis data. This study will serve as a pilot study and assess patient gait, degree of pain, functional outcome scores, development of post-traumatic arthritis and/or infection, need for secondary surgery, and return to work time.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 25, 2023

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

September 13, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 18, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2023

Completed
Last Updated

October 18, 2023

Status Verified

October 1, 2023

Enrollment Period

4 months

First QC Date

September 13, 2023

Last Update Submit

October 12, 2023

Conditions

Keywords

Pilon Fracture

Outcome Measures

Primary Outcomes (5)

  • Ankle range of motion

    Inversion and eversion range, and flexion versus extension range determined by the use of the Opal sensors

    Collected only once; from 6 months post-op up to date of death from any cause

  • Walking cadence

    Steps per minute as determined by the use of the Opal Sensors

    Collected only once; from 6 months post-op up to date of death from any cause

  • Timed up-and-go

    Time it takes to stand from seated, walk 10 feet forward, turn around, and sit back down, unassisted (determined by the use of the Opal sensors).

    Collected only once; from 6 months post-op up to date of death from any cause

  • Foot and ankle Outcome Score (FAOS)

    Foot and ankle injury patient reported outcome measure (Scores range from 0 to 100, with higher scores indicating better foot and ankle surgical outcomes)

    Collected only once; from 6 months post-op up to date of death from any cause

  • 12 Item Short Form Survey (SF-12)

    Patient reported outcome measures regarding health and daily activities (Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning)

    Collected only once; from 6 months post-op up to date of death from any cause

Secondary Outcomes (3)

  • Presence of infection and/or post-traumatic arthritis

    From the date of surgery up until the date of death from any cause

  • Need for secondary operation

    From the date of surgery up until the date of death from any cause

  • Return to work time

    From the date of surgery up until the date of death from any cause

Study Arms (2)

Open reduction and internal fixation (ORIF)

Patient has underwent ORIF to repair a pilon fracture.

Primary arthrodesis (PA; ankle fusion)

Patient has underwent PA/ankle fusion to repair a pilon fracture.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals over the age of 18 that have undergone an ORIF or PA surgery for an acute pilon fracture at either KUMC or Emory University Hospital.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Kansas Medical Center

Kansas City, Kansas, 66103, United States

RECRUITING

Central Study Contacts

Brent Wise, MD

CONTACT

David Turkowitch, BS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 13, 2023

First Posted

October 18, 2023

Study Start

August 25, 2023

Primary Completion

December 25, 2023

Study Completion

December 25, 2023

Last Updated

October 18, 2023

Record last verified: 2023-10

Locations